On Wednesday UFC and Aurora Cannabis hosted a press conference to discuss their ground-breaking partnership that is expected to significantly advance clinical research on the relationship between 100% hemp derived Cannabidiol (CBD) products and athlete wellness and recovery.
Aurora is a Canadian company, which is currently working in 24 countries and started in 2013. The research will be conducted at the UFC’s Performance Institute in Las Vegas in collaboration with the Performance Institute’s expert staff, as well as with athletes who choose to participate in the studies.
Aurora’s research will be led by Dr. Jason Dyck, Professor at the University of Alberta and a Canada Research Chair in Molecular Medicine.